Position in IMVT
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,418,016
-$2,660,419 QoQ
Shares Held
57,086
-64.4% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. IMVT ranks #132 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in IMVT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,418,016 | 57,086 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,078,435 | 160,442 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,033,472 | 374,285 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,791,456 | 236,966 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,749,454 | 394,936 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $10,000,811 | 403,747 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $13,177,605 | 462,210 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $13,059,789 | 494,689 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $18,528,070 | 573,447 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $29,994,452 | 711,950 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $28,275,347 | 736,529 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $16,517,121 | 870,697 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $16,005,744 | 1,031,963 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,032,541 | 1,297,608 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,906,199 | 1,058,459 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,687,371 | 945,480 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,807,217 | 690,965 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,368,287 | 277,968 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $119,383 | 13,738 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||